Your browser doesn't support javascript.
loading
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells.
Haase-Kohn, Cathleen; Laube, Markus; Donat, Cornelius K; Belter, Birgit; Pietzsch, Jens.
Afiliação
  • Haase-Kohn C; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
  • Laube M; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
  • Donat CK; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Translational TME-Ligands, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
  • Belter B; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
  • Pietzsch J; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
Cells ; 11(4)2022 02 21.
Article em En | MEDLINE | ID: mdl-35203404

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclo-Oxigenase 2 / Sistemas CRISPR-Cas / Melanoma / Invasividade Neoplásica Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclo-Oxigenase 2 / Sistemas CRISPR-Cas / Melanoma / Invasividade Neoplásica Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article